IFI30 Antibody Guideline: Preparation, Dilution and Applications

IFI30 Antibody Overview

There are 5 IFI30 antibodies which are validated in multiple tissues with various applications, including ELISA, IHC-P, ICC/IF, WB. There are 4 IFI30 antibody for ELISA, 1 IFI30 antibody for IHC-P, 1 IFI30 antibody for ICC/IF, 1 IFI30 antibody for WB. Among all these IFI30 antibodies, there are 1 anti-IFI30 mouse monoclonal antibodies , 2 anti-IFI30 rabbit monoclonal antibodies , 2 anti-IFI30 rabbit polyclonal antibodies . All the IFI30 anbodies are produced in house and all are in stock. IFI30 antibody customerized service is available.

IFI30 Antibody ELISA

IFI30 antibody ELISA preparation

This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human IFI30 (rh IFI30; Catalog#12623-H08H; P13284; Met1-Lys243). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.

IFI30 antibody ELISA validated

Application ELISA
Dilution 1:1000-1:2000
Notes  

IFI30 Antibody western blot

IFI30 Antibody western blot Preparation

Produced in rabbits immunized with purified, recombinant Human IFI30 (rh IFI30; Catalog#12623-H08H; P13284; Met1-Lys243). IFI30 specific IgG was purified by Human IFI30 affinity chromatography.

IFI30 Antibody western blot Validated

Application WB
Dilution 1:500-1:1000
Notes  

IFI30 Antibody immunohistochemistry

IFI30 Antibody immunohistochemistry Preparation

This antibody was obtained from a rabbit immunized with purified, recombinant Human IFI30 (rh IFI30; Catalog#12623-H08H; P13284; Met1-Lys243).

IFI30 Antibody immunohistochemistry Validated

Application IHC
Dilution 1:10000-1:20000
Notes  

IFI30 Antibody ICC / IF

IFI30 Antibody ICC / IF Preparation

This antibody was obtained from a rabbit immunized with purified, recombinant Human IFI30 (rh IFI30; Catalog#12623-H08H; P13284; Met1-Lys243).

IFI30 Antibody ICC / IF Validated

Application ICC_IF
Dilution 1:20-1:100
Notes